The presentation will analyse the key Point-of-care (POC) tests available and recommended to monitor septic patients. The added value of POC will be supported by published references and professional guidelines. Tests that only recently have become available as POC will also be presented and their importance in the management of septic patients will also be discussed in light of the scientific literature and the clinical experience available.
Nova Biomedical is a company dedicated to using advanced technology to develop better blood testing analyzers for medical use. These products are called in vitro diagnostic devices (IVD). We use some of the same advanced technology to provide the biotechnology industry with innovative instruments for cell culture monitoring. Nova is the largest privately owned IVD company in the U.S. and the third largest in the world, with over 1,200 employees globally. Our eight percent compounded annual growth over nearly a decade is more than double the IVD market growth, making Nova one the fastest growing IVD companies in the world.